Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
136.81
-3.22 (-2.30%)
At close: Dec 5, 2025, 4:00 PM EST
138.38
+1.57 (1.15%)
After-hours: Dec 5, 2025, 7:48 PM EST
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $224.50M in the quarter ending September 30, 2025, with 10.49% growth. This brings the company's revenue in the last twelve months to $882.62M, up 16.81% year-over-year. In the year 2024, Inspire Medical Systems had annual revenue of $802.80M with 28.49% growth.
Revenue (ttm)
$882.62M
Revenue Growth
+16.81%
P/S Ratio
4.59
Revenue / Employee
$708,364
Employees
1,246
Market Cap
3.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
INSP News
- 1 day ago - Inspire Medical Systems, Inc. (INSP) Investors are Encouraged to Act before the Upcoming January 5 Securities Fraud Deadline – Contact BFA Law if You Lost Money - GlobeNewsWire
- 1 day ago - Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 - PRNewsWire
- 1 day ago - INSP LAWSUIT DEADLINE: Hagens Berman Urges Inspire Medical Investors to Act by Jan. 5 Over 32% Crash and “Inspire V” Launch Failure - GlobeNewsWire
- 2 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - GlobeNewsWire
- 3 days ago - INSP NEWS: Inspire Medical Systems, Inc. Sued for Securities Fraud after Stock Plummets 32% -- Investors Notified to Contact BFA Law by January 5 Deadline - GlobeNewsWire
- 4 days ago - Inspire Medical Systems, Inc. (INSP) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - Newsfile Corp
- 4 days ago - INSP SHAREHOLDERS: Inspire Medical Systems, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 5 - Newsfile Corp